SCHEMBL4700441

SCHEMBL4700441

CN(CC(=O)O)C(=O)c1cnc(NNC(=O)NC2c3ccccc3CCc3ccccc32)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 3/20 0.38
ROCK2 O75116 3/20 0.34
ALDH1A1 P00352 1/20 0.34
HTR2C P28335 1/20 0.33
SLC6A3 Q01959 1/20 0.33
TAS1R3 Q7RTX0 2/20 0.33
TAS1R1 Q7RTX1 2/20 0.33
OPRM1 P35372 2/20 0.33
OPRK1 P41145 2/20 0.33
ENPP2 Q13822 1/20 0.33
OPRL1 P41146 1/20 0.33
HPGDS O60760 1/20 0.32
SLC8A1 P32418 1/20 0.32
KMT2A Q03164 2/20 0.32
TAS1R2 Q8TE23 1/20 0.32
OPRD1 P41143 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4698850 0.91 BDKRB2 (0.35) BDKRB2ROCK2ALDH1A1HTR2CSLC6A3
SCHEMBL4698936 0.89 BDKRB2 (0.36) BDKRB2ROCK2ALDH1A1TAS1R3TAS1R1
SCHEMBL4698835 0.87 ROCK2 (0.36) BDKRB2ROCK2ALDH1A1MAPTSMN1; SMN2
SCHEMBL4700242 0.85 PDK1 (0.40) BDKRB2ROCK2KMT2AMEN1
SCHEMBL4756002 0.85 ALDH1A1 (0.39) BDKRB2ALDH1A1HTR2CSLC6A3TAS1R3
SCHEMBL4702892 0.85 BDKRB2 (0.48) BDKRB2ROCK2ALDH1A1HTR2CSLC6A3
SCHEMBL4702365 0.84 OPRM1 (0.34) BDKRB2ROCK2ALDH1A1HTR2CSLC6A3
SCHEMBL4698590 0.83 BDKRB2 (0.40) BDKRB2ROCK2ALDH1A1KMT2AOPRD1
SCHEMBL6387629 0.83 BDKRB2 (0.43) BDKRB2ALDH1A1HTR2CSLC6A3ENPP2
SCHEMBL4701332 0.81 GAA (0.40) ALDH1A1KMT2AMEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458684-B1 THERAPEUTIC HETEROCYCLES AS BRADYKININ B2 RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2008-01-16 EP claimed